
    
      A Multicenter, double blind, randomized trial in which each volunteer will receive one of 2
      dose concentrations of one of two lots of Aventis Pasteur Smallpox Vaccine as a single
      vaccination (undiluted, 1:5 dilution). Volunteers without a take at day 7 - 9 will be offered
      a vaccination with Dryvax at the end of the study.
    
  